Reciprocal regulation of the survival and apoptosis of Th17 and Th1 cells in the colon

Inflammatory Bowel Diseases

Volumn 18, Issue 2, 2012, Pages 333-343

  Ustyugova, Irina V ^a,c   Zhi, Liang ^a   Wu, Mei X ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c SANOFI PASTEUR   (France)

Author keywords

apoptosis; IEX 1; Th1 and Th17 cell subsets

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; NEUTRALIZING ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; GENE; GENE INACTIVATION; IMMEDIATE EARLY RESPONSE GENE X 1; LAMINA PROPRIA; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECOMBINATION ACTIVATING GENE 1; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; WILD TYPE;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; CELL SURVIVAL; COLITIS; FEMALE; IMMEDIATE-EARLY PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOUS MEMBRANE; T-LYMPHOCYTES; TH1 CELLS; TH17 CELLS;

EID: 84855705638     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21772     Document Type: Article

References (38)

1. Uhlig HH, Coombes J, Mottet C, et al. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol. 2006; 177: 5852-5860.
2. Stallmach A, Marth T, Weiss B, et al. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo. Gut. 2004; 53: 339-345. (Pubitemid 38241326)
3. Neurath MF, Finotto S, Fuss I, et al. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol. 2001; 22: 21-26. (Pubitemid 32675276)
4. Atreya R, Atreya I, Neurath MF,. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease. Ann N Y Acad Sci. 2006; 1072: 98-113. (Pubitemid 44448446)
5. Tiede I, Fritz G, Strand S, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest. 2003; 111: 1133-1145. (Pubitemid 36519931)
6. Chen Y, Thai P, Zhao YH, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem. 2003; 278: 17036-17043. (Pubitemid 36799579)
7. Chabaud M, Lubberts E, Joosten L, et al. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001; 3: 168-177. (Pubitemid 32303433)
8. Wong CK, Ho CY, Li EK, et al. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus. 2000; 9: 589-593.
9. Linden A,. Role of interleukin-17 and the neutrophil in asthma. Int Arch Allergy Immunol. 2001; 126: 179-184. (Pubitemid 34042823)
10. Zhang Z, Zheng M, Bindas J, et al. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis. 2006; 12: 382-388.
11. Kinugasa T, Sakaguchi T, Gu X, et al. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology. 2000; 118: 1001-1011. (Pubitemid 30346975)
12. Ogawa A, Andoh A, Araki Y, et al. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol. 2004; 110: 55-62. (Pubitemid 38177420)
13. O'Connor W Jr, Kamanaka M, Booth CJ, et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009; 10: 603-509.
14. Wu MX,. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis. 2003; 8: 11-18. (Pubitemid 36133133)
15. Zhang Y, Schlossman SF, Edwards RA, et al. Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci U S A. 2002; 99: 878-883. (Pubitemid 34106604)
16. Zhang Y, Finegold MJ, Porteu F, et al. Development of T-cell lymphomas in Emu-IEX-1 mice. Oncogene. 2003; 22: 6845-6851. (Pubitemid 37386683)
17. Shen L, Guo J, Santos-Berrios C, et al. Distinct domains for anti- and pro-apoptotic activities of IEX-1. J Biol Chem. 2006; 281: 15304-15311. (Pubitemid 43855120)
18. Sasada T, Azuma K, Hirai T, et al. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer. Ann Surg Oncol. 2008; 15: 609-617.
19. Schilling D, Pittelkow MR, Kumar R,. IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene. 2001; 20: 7992-7997. (Pubitemid 34001560)
20. Steensma DP, Neiger JD, Porcher JC, et al. Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes. Cancer Res. 2009; 69: 7518-7523.
21. Shen L, Zhi L, Hu W, et al. IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation. Cell Death Differ. 2009; 16: 603-612.
22. Shahid M, Shen L, Seldin DC, et al. Impaired 3â ,5â -cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene S-1-deficient vascular smooth muscle cells. Hypertension. 2010; 56: 705-712.
23. Akilov OE, Ustyugova IV, Zhi L, et al. Enhanced susceptibility to leishmania infection in resistant mice in the absence of immediate early response gene X-1. J Immunol. 2009; 183: 7994-8003.
24. Kitajima S, Takuma S, Morimoto M,. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 1999; 48: 137-143. (Pubitemid 129558679)
25. Powrie F, Leach MW, Mauze S, et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1994; 1: 553-562.
26. Read S, Malmstrom V, Powrie F,. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000; 192: 295-302. (Pubitemid 30470312)
27. Boise LH, Thompson CB,. Hierarchical control of lymphocyte survival. Science. 1996; 274: 67-68. (Pubitemid 26332723)
28. Peppelenbosch MP, van Deventer SJ,. T cell apoptosis and inflammatory bowel disease. Gut. 2004; 53: 1556-1558. (Pubitemid 39434092)
29. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med. 2000; 6: 583-588. (Pubitemid 30305911)
30. Fuss IJ, Marth T, Neurath MF, et al. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology. 1999; 117: 1078-1088. (Pubitemid 29512666)
31. Yu QT, Saruta M, Papadakis KA,. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin Immunol. 2008; 127: 322-329.
32. Van den Brande JM, Braat H, van den Brink GR, et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology. 2003; 124: 1774-1785. (Pubitemid 36666774)
33. Agnholt J, Kelsen J, Brandsborg B, et al. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's diseaseâ a possible target for infliximab treatment. Eur J Gastroenterol Hepatol. 2004; 16: 649-655. (Pubitemid 38901632)
34. Sands BE, Tremaine WJ, Sandborn WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis. 2001; 7: 83-88.
35. Sugihara T, Kobori A, Imaeda H, et al. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin Exp Immunol. 2010; 160: 386-393.
36. Sina C, Arlt A, Gavrilova O, et al. Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. Inflamm Bowel Dis. 2010; 16: 320-331.
37. Mahler M, Bristol IJ, Leiter EH, et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol. 1998; 274: G544-G551.
38. Garlanda C, Riva F, Veliz T, et al. Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 2007; 67: 6017-6021. (Pubitemid 47037479)